Nuclear medicine therapy?is an approach to treating cancer that might be used with or after other treatment options, such as chemotherapy and surgery. It won't usually lead to a cure unless combined with other therapies.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Therapeutic Nuclear Medicines industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Radium-223
Lutetium-177
Iodine-131
Other
Market Segment by Product Application
Thyroid
Bone Metastasis
Lymphoma
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Bayer
Novartis AG
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Therapeutic Nuclear Medicines consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Therapeutic Nuclear Medicines market by identifying its various subsegments.
3.Focuses on the key global Therapeutic Nuclear Medicines manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Therapeutic Nuclear Medicines with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Therapeutic Nuclear Medicines submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Therapeutic Nuclear Medicines Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Therapeutic Nuclear Medicines Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Therapeutic Nuclear Medicines Segment by Type
2.1.1 Radium-223
2.1.2 Lutetium-177
2.1.3 Iodine-131
2.1.4 Other
2.2 Market Analysis by Application
2.2.1 Thyroid
2.2.2 Bone Metastasis
2.2.3 Lymphoma
2.2.4 Other
2.3 Global Therapeutic Nuclear Medicines Market Comparison by Regions (2017-2027)
2.3.1 Global Therapeutic Nuclear Medicines Market Size (2017-2027)
2.3.2 North America Therapeutic Nuclear Medicines Status and Prospect (2017-2027)
2.3.3 Europe Therapeutic Nuclear Medicines Status and Prospect (2017-2027)
2.3.4 China Therapeutic Nuclear Medicines Status and Prospect (2017-2027)
2.3.5 Japan Therapeutic Nuclear Medicines Status and Prospect (2017-2027)
2.3.6 Southeast Asia Therapeutic Nuclear Medicines Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Therapeutic Nuclear Medicines Industry Impact
2.5.1 Therapeutic Nuclear Medicines Business Impact Assessment - Covid-19
2.5.2 Market Trends and Therapeutic Nuclear Medicines Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Therapeutic Nuclear Medicines Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Therapeutic Nuclear Medicines Manufacturer Market Share
3.5 Top 10 Therapeutic Nuclear Medicines Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Therapeutic Nuclear Medicines Market
3.7 Key Manufacturers Therapeutic Nuclear Medicines Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Therapeutic Nuclear Medicines Industry Key Manufacturers
4.1 Bayer
4.1.1 Compan Detail
4.1.2 Bayer Therapeutic Nuclear Medicines Product Introduction, Application and Specification
4.1.3 Bayer 167 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Bayer News
4.2 Novartis AG
4.2.1 Compan Detail
4.2.2 Novartis AG Therapeutic Nuclear Medicines Product Introduction, Application and Specification
4.2.3 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Bayer News
4.3 China Isotope & Radiation
4.3.1 Compan Detail
4.3.2 China Isotope & Radiation Therapeutic Nuclear Medicines Product Introduction, Application and Specification
4.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 China Isotope & Radiation News
4.4 Dongcheng
4.4.1 Compan Detail
4.4.2 Dongcheng Therapeutic Nuclear Medicines Product Introduction, Application and Specification
4.4.3 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Dongcheng News
4.5 Q BioMed
4.5.1 Compan Detail
4.5.2 Dongcheng Therapeutic Nuclear Medicines Product Introduction, Application and Specification
4.5.3 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Q BioMed News
4.6 Curium Pharmaceuticals
4.6.1 Compan Detail
4.6.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Introduction, Application and Specification
4.6.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Curium Pharmaceuticals News
4.7 Jubilant DraxImage
4.7.1 Compan Detail
4.7.2 Jubilant DraxImage Therapeutic Nuclear Medicines Product Introduction, Application and Specification
4.7.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Lantheus
4.8.1 Compan Detail
4.8.2 Lantheus Therapeutic Nuclear Medicines Product Introduction, Application and Specification
4.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Lantheus News
4.9 Spectrum Pharmaceuticals
4.9.1 Compan Detail
4.9.2 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Product Introduction, Application and Specification
4.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Spectrum Pharmaceuticals News
4.10 Progenics Pharmaceuticals
4.10.1 Compan Detail
4.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Introduction, Application and Specification
4.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Progenics Pharmaceuticals News
4.11 International Isotopes
4.11.1 Compan Detail
4.11.2 International Isotopes Therapeutic Nuclear Medicines Product Introduction, Application and Specification
4.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 International Isotopes News
5 Global Therapeutic Nuclear Medicines Market Segment by Big Type
5.1 Global Therapeutic Nuclear Medicines Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Big Type (2017-2022)
5.2 Radium-223 Sales Growth Rate and Price
5.2.1 Global Radium-223 Sales Growth Rate (2017-2022)
5.2.2 Global Radium-223 Price (2017-2022)
5.3 Lutetium-177 Sales Growth Rate and Price
5.3.1 Global Lutetium-177 Sales Growth Rate (2017-2022)
5.3.2 Global Lutetium-177 Price (2017-2022)
5.4 Iodine-131 Sales Growth Rate and Price
5.4.1 Global Iodine-131 Sales Growth Rate (2017-2022)
5.4.2 Global Iodine-131 Price (2017-2022)
5.5 Other Sales Growth Rate and Price
5.5.1 Global Other Sales Growth Rate (2017-2022)
5.5.2 Global Other Price (2017-2022)
6 Global Therapeutic Nuclear Medicines Market Segment by Big Application
6.1 Global Therapeutic Nuclear Medicines Sales Market Share by Big Application (2017-2022)
6.2 Thyroid Sales Growth Rate (2017-2022)
6.3 Bone Metastasis Sales Growth Rate (2017-2022)
6.4 Lymphoma Sales Growth Rate (2017-2022)
6.5 Other Sales Growth Rate (2017-2022)
7 Global Therapeutic Nuclear Medicines Forecast
7.1 Global Therapeutic Nuclear Medicines Revenue, Sales and Growth Rate (2022-2027)
7.2 Therapeutic Nuclear Medicines Market Forecast by Regions (2022-2027)
7.2.1 North America Therapeutic Nuclear Medicines Market Forecast (2022-2027)
7.2.2 Europe Therapeutic Nuclear Medicines Market Forecast (2022-2027)
7.2.3 China Therapeutic Nuclear Medicines Market Forecast (2022-2027)
7.2.4 Japan Therapeutic Nuclear Medicines Market Forecast (2022-2027)
7.2.5 Southeast Asia Therapeutic Nuclear Medicines Market Forecast (2022-2027)
7.2.6 Other Regions Therapeutic Nuclear Medicines Market Forecast (2022-2027)
7.3 Therapeutic Nuclear Medicines Market Forecast by Type (2022-2027)
7.3.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2022-2027)
7.3.2 Global Therapeutic Nuclear Medicines Market Share Forecast by Type (2022-2027)
7.4 Therapeutic Nuclear Medicines Market Forecast by Application (2022-2027)
7.4.1 Global Therapeutic Nuclear Medicines Sales Forecast by Application (2022-2027)
7.4.2 Global Therapeutic Nuclear Medicines Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Therapeutic Nuclear Medicines Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Therapeutic Nuclear Medicines Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Therapeutic Nuclear Medicines
Figure Market Concentration Ratio and Market Maturity Analysis of Therapeutic Nuclear Medicines
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Therapeutic Nuclear Medicines Market Size by Big Type
Figure Global Market Share of Therapeutic Nuclear Medicines by Big Type in 2021
Figure Radium-223 Picture (2017-2022)
Figure Lutetium-177 Picture (2017-2022)
Figure Iodine-131 Picture (2017-2022)
Global Therapeutic Nuclear Medicines Market Size by Big Application
Table Global Therapeutic Nuclear Medicines Market Size by Application
Figure Global Therapeutic Nuclear Medicines Market Share by Big Application in 2021
Figure Thyroid Picture
Figure Bone Metastasis Picture
Figure Lymphoma Picture
Figure Other Picture
Table Global Therapeutic Nuclear Medicines Comparison by Regions (M USD) (2017-2027)
Figure Global Therapeutic Nuclear Medicines Market Size (Million US$) (2017-2027)
Figure North America Therapeutic Nuclear Medicines Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Therapeutic Nuclear Medicines Revenue (Million US$) Growth Rate (2017-2027)
Figure China Therapeutic Nuclear Medicines Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Therapeutic Nuclear Medicines Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Therapeutic Nuclear Medicines Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Therapeutic Nuclear Medicines Sales by Manufacturer (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturer in 2021
Table Global Therapeutic Nuclear Medicines Revenue by Manufacturer (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturer in 2021
Table Global Therapeutic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Therapeutic Nuclear Medicines Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Therapeutic Nuclear Medicines Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Therapeutic Nuclear Medicines Market
Table Key Manufacturers Therapeutic Nuclear Medicines Product Type
Table Mergers & Acquisitions Planning
Table Bayer Company Profile
Table Therapeutic Nuclear Medicines Product Introduction, Application and Specification of Bayer
Table Therapeutic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Novartis AG Company Profile
Table Therapeutic Nuclear Medicines Product Introduction, Application and Specification of Novartis AG
Table Therapeutic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis AG Recent Development
Table China Isotope & Radiation Company Profile
Table Therapeutic Nuclear Medicines Product Introduction, Application and Specification of China Isotope & Radiation
Table Therapeutic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table China Isotope & Radiation Main Business
Table China Isotope & Radiation Recent Development
Table Dongcheng Company Profile
Table Therapeutic Nuclear Medicines Product Introduction, Application and Specification of Dongcheng
Table Therapeutic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Dongcheng Main Business
Table Dongcheng Recent Development
Table Dongcheng Main Business
Table Dongcheng Recent Development
Table Q BioMed Company Profile
Table Therapeutic Nuclear Medicines Product Introduction, Application and Specification of Q BioMed
Table Therapeutic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Q BioMed Main Business
Table Q BioMed Recent Development
Table Curium Pharmaceuticals Company Profile
Table Therapeutic Nuclear Medicines Product Introduction, Application and Specification of Curium Pharmaceuticals
Table Therapeutic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Curium Pharmaceuticals Main Business
Table Curium Pharmaceuticals Recent Development
Table Jubilant DraxImage Company Profile
Table Therapeutic Nuclear Medicines Product Introduction, Application and Specification of Jubilant DraxImage
Table Therapeutic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Jubilant DraxImage Main Business
Table Jubilant DraxImage Recent Development
Table Lantheus Company Profile
Table Therapeutic Nuclear Medicines Product Introduction, Application and Specification of Lantheus
Table Therapeutic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Lantheus Main Business
Table Lantheus Recent Development
Table Spectrum Pharmaceuticals Company Profile
Table Therapeutic Nuclear Medicines Product Introduction, Application and Specification of Spectrum Pharmaceuticals
Table Therapeutic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Spectrum Pharmaceuticals Main Business
Table Spectrum Pharmaceuticals Recent Development
Table Progenics Pharmaceuticals Company Profile
Table Therapeutic Nuclear Medicines Product Introduction, Application and Specification of Progenics Pharmaceuticals
Table Therapeutic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Progenics Pharmaceuticals Main Business
Table Progenics Pharmaceuticals Recent Development
Table International Isotopes Company Profile
Table Therapeutic Nuclear Medicines Product Introduction, Application and Specification of International Isotopes
Table Therapeutic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table International Isotopes Main Business
Table International Isotopes Recent Development
Figure Global Therapeutic Nuclear Medicines Sales and Growth Rate (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales by Regions (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Regions in 2021
Table Global Therapeutic Nuclear Medicines Revenue by Regions (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Regions in 2021
Figure North America Therapeutic Nuclear Medicines Sales and Growth Rate (2017-2022)
Figure Europe Therapeutic Nuclear Medicines Sales and Growth Rate (2017-2022)
Figure China Therapeutic Nuclear Medicines Sales and Growth Rate (2017-2022)
Figure Japan Therapeutic Nuclear Medicines Sales and Growth Rate (2017-2022)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales and Growth Rate (2017-2022)
Figure Other Regions Therapeutic Nuclear Medicines Sales and Growth Rate (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales by Big Type (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Market Share by Big Type (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Big Type in 2019
Table Global Therapeutic Nuclear Medicines Revenue by Big Type (2017-2022)
Table Global Therapeutic Nuclear Medicines Revenue Market Share by Big Type (2017-2022)
Table Global Therapeutic Nuclear Medicines Revenue Market Share by Big Type in 2019
Figure Global Radium-223 Sales Growth Rate (2017-2022)
Figure Global Radium-223 Price (2017-2022)
Figure Global Lutetium-177 Sales Growth Rate (2017-2022)
Figure Global Lutetium-177 Price (2017-2022)
Figure Global Iodine-131 Sales Growth Rate (2017-2022)
Figure Global Iodine-131 Price (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales by Big Application (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Market Share by Big Application (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Big Application in 2019
Figure Global Thyroid Sales Growth Rate (2017-2022)
Figure Global Bone Metastasis Sales Growth Rate (2017-2022)
Figure Global Lymphoma Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales and Growth Rate (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue and Growth Rate (2022-2027)
Table Global Therapeutic Nuclear Medicines Sales Forecast by Regions (2022-2027)
Table Global Therapeutic Nuclear Medicines Market Share Forecast by Regions (2022-2027)
Figure North America Sales Therapeutic Nuclear Medicines Market Forecast (2022-2027)
Figure Europe Sales Therapeutic Nuclear Medicines Market Forecast (2022-2027)
Figure China Sales Therapeutic Nuclear Medicines Market Forecast (2022-2027)
Figure Japan Sales Therapeutic Nuclear Medicines Market Forecast (2022-2027)
Figure Southeast Asia Sales Therapeutic Nuclear Medicines Market Forecast (2022-2027)
Figure Other Regions Sales Therapeutic Nuclear Medicines Market Forecast (2022-2027)
Table Global Therapeutic Nuclear Medicines Sales Forecast by Type (2022-2027)
Table Global Therapeutic Nuclear Medicines Market Share Forecast by Type (2022-2027)
Table Global Therapeutic Nuclear Medicines Sales Forecast by Application (2022-2027)
Table Global Therapeutic Nuclear Medicines Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Therapeutic Nuclear Medicines Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Therapeutic Nuclear Medicines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Therapeutic Nuclear Medicines Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Therapeutic Nuclear Medicines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Therapeutic Nuclear Medicines Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Therapeutic Nuclear Medicines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Therapeutic Nuclear Medicines Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Therapeutic Nuclear Medicines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Bayer
Novartis AG
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)